Table II.
Cycle performance indicators | Before PRP | Following PRP |
---|---|---|
Duration of stimulation (days) | 10.1±2.47 | 10.0±1.56 |
Gonadotropin dose (IU) | 4,002.50±856.93 | 3,801.50±521.68 |
Estradiol (pg/ml) (HCG trigger) | 603.75±262.24 | 907.75±386.56b |
Cancellation rate | 40.0% (8/20) | 15.0% (3/20) |
Retrieved oocytesa | 0.80±0.83 | 1.8±1.15 |
MII oocytes obtaineda | 0.75±0.62 | 1.51±0.87 |
Good quality embryos (A and B)a | 0.33±0.49 | 0.76±0.75 |
aCalculated without taking into account the cancelled cases. Data are represented as mean ± SD or frequency (%).
bP<0.05, significant difference in comparison to before PRP treatment. PRP, platelet-rich plasma; HCG, human chorionic gonadotropin; MII, metaphase II.